Skip to main content
. 2019 Mar;60(3):353–361. doi: 10.2967/jnumed.118.216069

FIGURE 5.

FIGURE 5.

18F-AlF-NOTA-ZEGFR:03115 uptake assessed 1 h after injection. (A) Representative sagittal whole-body PET/CT images of mice bearing HN5 tumors (outlined on image) with or without treatment with cetuximab. (B) PET quantification in control and cetuximab-treated HN5 tumors and corresponding biodistribution %ID/g values. Data are mean ± SD (n ≥ 6). ****P < 0.0001.